| Name |
Administration |
Indication |
| Sabril® (vigabatrin) |
oral |
Seizures/Infantile Spasms |
| Saizen® (somatropin [rDNA origin]) |
SAI |
Growth Stimulant |
| Samsca™ (tolvaptan) |
oral |
Hyponatremia |
| Sandostatin® (octreotide acetate) |
SAI |
Cancer |
| Sandostatin LAR® (octreotide/IM) |
SAI |
Cancer |
| Sensipar® (cinacalcet hydrochloride) |
oral |
Hypercalcemia/ Hyperparathyroidism |
| Serostim® (somatropin [rDNA origin]) |
SAI |
HIV Wasting |
| Simponi™ (golimumab) |
SAI |
Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriasis |
| Soliris® (eculizumab) |
non-SAI |
Paroxysmal Nocturnal Hemoglobinuria |
| Somatuline Depot® (lanreotide) |
SAI |
Acromegaly |
| Somavert® (pegvisomant) |
SAI |
Acromegaly |
| Sprycel® (dasatinib) |
oral |
Cancer |
| Stelara™ (ustekinumab) |
non-SAI |
Psoriasis |
| Stimate® (desmopressin acetate) |
nasal inhalation |
Hemophilia |
| Supartz® (sodium hyaluronate) |
non-SAI |
Osteoarthritis |
| Supprelin®LA (histrelin acetate) |
SAI |
Central Precocious Puberty |
| Sutent® capsules (sunitinib malate) |
oral |
Cancer |
| Synagis® (palivizumab) |
non-SAI |
Respiratory Syncytial Virus |
| Synvisc®/Synvisc-One® (hylan G-F 20) |
non-SAI |
Osteoarthritis |